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Abstract 
A 37-year-old woman presented to the Internal Medicine Clinic with complaints of 
abdominal pain and constipation which had begun 3 months earlier. A colonoscopy was 
performed, and wall thickening of the sigmoid colon was detected. A biopsy of the sigmoid 
colon revealed a poorly differentiated, mucin-producing adenocarcinoma with a signet-ring 
pattern. No distant metastasis was detected. The patient was treated with chemotherapy 
consisting of 5-fluorouracil, leucovorin, and oxaliplatin. One and a half years later, a painless 
mass, which was not fixed to the skin, measuring 1 cm in diameter, was found in the lower 
outer quadrant of the left breast. A core biopsy of the mass was performed, and a 
histopathological report confirmed metastasis to the breast from mucinous adenocarcinoma 
of an intestinal primary. 
 
Introduction 
Colorectal cancer is the third most common cancer in the world. Cancer of the colon 
most commonly spreads to the lymph nodes, liver, lungs, and bones, in that order. 
Metastasis of colon cancer to the breast is quite rare. Although primary breast 
carcinoma is the most common tumor in women, even in patients with a history of 
cancer from other organs, metastases to the breast from solid tumors may be detected 
[1, 2]. The most common primary tumor to metastasize to the breast is contralateral 
breast carcinoma. Every mass found in the breast should not inherently be regarded as 
primary breast cancer, and it should be kept in mind that, in a patient with a history of 
a solid tumor, the mass could be a metastasis of that solid tumor. Here, we report a rare 
case of aggressive colon cancer with metastasis to the breast, without liver or lung 
metastases. The patient was started on palliative chemotherapy with irinotecan, 5-
fluorouracil (5-FU), and leucovorin (FOLFOX4). Management of breast cancer 
metastasis is discussed below, accompanied by a review of the literature.  
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Case Report 
A 37-year-old woman presented to the Internal Medicine Clinic with complaints of abdominal pain 
and constipation which had begun 3 months earlier. Physical examination was unremarkable. A 
colonoscopy was performed, and wall thickening of the sigmoid colon was detected. A biopsy revealed 
poorly differentiated mucin-producing adenocarcinoma with a signet-ring pattern (fig. 1a). No distant 
metastasis was detected. After sigmoidectomy for T3N3M0 (stage III) adenocarcinoma of the colon, 
adjuvant FOLFOX4 was administered for six cycles on days 1 and 15, every two weeks. 
One and a half years later, a painless mass, which was not fixed to the skin, measuring 1 cm in 
diameter, was found in the lower outer quadrant of the left breast. Mammography showed a well-
defined nodule without microcalcifications and axillary lymphadenopathy, 1 × 1 cm in size. Positron 
emission tomography showed a high FDG uptake in the left breast (fig. 2). In this clinical context, the 
suspicion that the patient’s breast lump represented a metastatic deposit of her colon cancer was 
raised. 
A core biopsy of the breast mass was performed. A histopathological study confirmed metastasis 
to the breast from a mucinous adenocarcinoma of gastrointestinal origin and a colonic-type pattern 
with signet-ring cells. Immunohistochemical results were negative for estrogen and progesterone 
receptors and GCDFP-15, and positive for cytokeratin 20 (CK-20) (fig. 1b). Surgical treatment was not 
preferred, and the patient was then started on palliative FOLFOX4 chemotherapy. 
Discussion 
Colorectal cancer is the third most common cancer in the world and second most 
common cause of cancer mortality after lung cancer. The risk for colorectal cancer 
increases with age, but 3% of colorectal cancers occur in patients younger than 40 
years of age. Multiple factors like polyps, diet, inflammatory bowel disease, genetics, 
and smoking drive the transformation of healthy colorectal mucosa to cancer. Genetic 
and environmental factors, such as maintaining a low body mass index and exercising 
regularly, correlate with lower incidence rates. Metastases to the regional lymph nodes 
are found in 40–70% of cases at the time of resection, with metastases to more distant 
sites occurring most frequently in the liver, peritoneal cavity, and lung, followed by the 
adrenals, ovaries, and bone [3]. Metastatic spread of colonic tumors to the breast is rare 
and is usually in the context of widespread disease. When the disease is detected in its 
early, localized stages, the five-year survival rate is approximately 90%. The prognosis 
for patients with metastatic disease is poor. In patients with distant metastases, the 
five-year survival rate is approximately 10% [4]. Cancers of the colon, uterine corpus, 
breast and ovary frequently occur together, suggesting an underlying hormonal or 
dietary effect [5]. 
Primary breast cancer is the most common cancer afflicting women (incidence of 
1/8–10), and it is the second leading cause of cancer death overall (following lung 
cancer). Breast cancer which is detected early is curable, but it has a 10–20% chance of 
distant metastases occurring even 10–20 years after the initial diagnosis [6]. The most 
common sites of breast cancer metastasis are bone, lungs, and the liver [7]. Metastatic 
cancer to the breast is very rare [8, 9]. The most common primary tumor is a 
contralateral breast carcinoma, followed by leukemia, melanoma, lymphoma, and 
ovary, lung, and gastric cancer [10]. 
Mammographic evaluation can be useful in the differential diagnosis of primary 
versus secondary breast cancer [10]. Metastasis to the breast from extramammary  
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malignancies usually presents as rapidly growing mobile masses that are easily 
palpable but do not cause an overlying skin or nipple retraction [11]. The 
mammographic finding in such a case is a rounded and well-circumscribed mass. 
Typically, there is no spiculation, microcalcification or thickening of the skin [10]. As 
metastatic neoplasms can mimic benign or primary breast neoplasms clinically and 
radiologically, differential diagnosis between primary and metastatic breast neoplasms 
is not always easy. Because treatment can differ profoundly, accurate diagnosis is of 
paramount importance to avoid unnecessary radical surgical procedures. Excisional or 
incisional biopsy is the most commonly used procedure for diagnosis [6]. 
In some equivocal cases, immunohistochemistry can help to make an accurate 
diagnosis [1]. The great majority of breast tumors are CK7 positive and CK20 negative, 
while colorectal carcinomas are usually CK7 negative and CK20 positive. When a breast 
tumor is negative for all breast markers (ER, PR, Her2, GCDP15, BCA, and CK7) and 
positive for CK20 and CDX2, this identifies the tumor as being colon cancer metastatic 
to the breast [4]. If the patient is found to have a tumor of breast origin, treatment 
would include local excision, radiotherapy, and, if the tumor is receptor positive, 
systemic hormonal manipulation [4]. 
There are 20 cases of colon cancer metastatic to the breast in the literature. The real 
incidence is difficult to estimate and is probably much higher [12]. Typically, these 
cases are associated with disseminated metastatic disease and imply a poor prognosis 
[10, 13]. Mastectomy in this setting, other than palliation, has a limited role. The main 
form of treatment for these patients is systemic chemotherapy [7]. 
In conclusion, colon cancer metastatic to the breast is very rare. Metastasis to the 
breast usually indicates disseminated disease, and the prognosis is poor. Mastectomy is 
controversial, and standard systemic treatment should be applied. 
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Fig. 1. a Sigmoid colon: signet-ring pattern component, poorly differentiated adenocarcinoma with an 
extracellular mucin-producing component, invasion of submucosal blood vessels (×400). b Trucut 
biopsy of the left breast: poorly differentiated adenocarcinoma with extracellular mucin and a focal 
signet-ring component, estrogen and progesterone negative (ER ×100, PR ×200). 
 
 
 
Fig. 2. A 37-year-old woman with a history of sigmoid colon cancer underwent FDG PET/CT imaging 
for restaging of the primary disease. Therefore she was intravenously injected 475 MBq (12.8 mCi) of 
18F-FDG after a 6-hour fasting period. After 1 h of waiting time in a silent room, the patient was 
imaged using an integrated PET/CT camera, which consists of a 6-slice CT gantry integrated in a LSO-
based fullring PET scanner (Siemens Biograph 6, Ill., USA). FDG PET/CT images showed a 
hypermetabolic lesion in the left breast consistent with malign lesions. 
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